Company intelligence
DrugCard
AI-powered pharmacovigilance automation platform for global and local literature monitoring and regulatory intelligence.
About DrugCard
DrugCard provides a cost-effective and regulatory compliant platform that automates pharmacovigilance — from global and local literature monitoring to regulatory tracking and case management. We help PV teams save time, stay compliant, and never miss a signal. Powered by AI, DrugCard transforms complex data into actionable insights, automates reporting and literature screening, and allows experts to focus on what matters most — strategic decisions and patient safety. Automated Local and Global Literature Monitoring Monitor both global databases like PubMed and local journals in one place. We already cover 151+ countries and 2300+ local journals, and counting. We add any journal you need — fast and without bureaucracy. No missed publications. No manual searches. Just faster, safer pharmacovigilance. AI-Powered Regulatory Intelligence Receive updates from global and local authorities in one centralized view — no more checking dozens of websites manually. DrugCard keeps your team informed on every regulatory change so you can act fast, stay compliant, and focus on what’s next — not on chasing updates. Adverse Event Database & Software Manage safety cases with an interface that feels intuitive, not overwhelming. Get the full “enterprise” functionality without the complexity, cost, or six months of training. Everything you need to collect, assess, and track adverse events efficiently — all in one secure, audit-ready platform. SimpleSearch — Free Tool for Drug Safety Searches It lets you explore global literature instantly, no setup or subscription required. It’s fast, accurate, and built for PV professionals who need reliable results — right now. Pharmacovigilance Services Extend your in-house capabilities with our PV specialists. DrugCard combines automation with human expertise — from literature review and reporting to quality checks and documentation. You get precision, consistency, and compliance delivered by experts who understand your needs.
Verified activity
Signals from DrugCard
7 published signals
Technology & Infrastructure
DrugCard's web crawler DrugCardBot has been officially verified by Cloudflare and listed in their public Bots Directory as a Verified bot.
Reported by DrugCard
Presence & Recognition
DrugCard is attending the World Patient Safety Congress Europe 2026 in Amsterdam at Booth 507 from 22 to 24 September 2026.
Reported by DrugCard
Presence & Recognition
DrugCard released the recording of a webinar featuring Dmytro Horilyk and Jan Kolouch following a demo.
Reported by DrugCard
Presence & Recognition
DrugCard ran a live webinar titled What the Demo Doesn't Show: Lessons from Selecting and Implementing Computerised Systems in Pharmacovigilance with Jan Kolouch, covering vendor selection, data migration, and integrations.
Reported by Dmytro Horilyk
Products & Services
DrugCard released the final version of the cases file for pharmacovigilance activity.
Reported by Dmytro Horilyk
Research & Knowledge
DrugCard published a safety review of a patient presenting with dyspnea and marked tachypnea, who was taking metformin, hydrochlorothiazide, and furosemide, with acute renal failure requiring emergency hemodialysis.
Reported by DrugCard
Research & Knowledge
DrugCard identified an MHRA Drug Safety Update on botulinum toxin type A highlighting updated warnings about the risk of iatrogenic botulism and risks associated with use outside licensed indications.
Reported by DrugCard